Given that the spleen is a hospitable site for Vk*MYC cells to reside, it is possible that the increased splenic tumour burden in HFD mice may not be due to changes in metabolic signalling but rather an increased availability of MM niches resulting from HFD-induced splenomegaly. The gene discussed is MYC; the disease is neoplasm.